← Eichor
Condition: Autoimmune Diseases Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Autoimmune Diseases

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

China Diabetes Type 1 Study (CD1S) by China Alliance for Type 1 Diabetes
Phase N/A · 11 location(s) · Second Xiangya Hospital of Central South University · NCT05498974Markers of Favorable Response to FcRn Inhibitors(INFORM)
Phase N/A · 1 location(s) · Fondazione Policlinico Universitario Agostino Gemelli IRCCS · NCT06685055A Worldwide Pregnancy Safety Study to Assess Maternal, Fetal, and Infant Outcomes Following Exposure to Efgartigimod Dur
Phase N/A · 4 location(s) · argenx · NCT06299748Unravelling The Optimisation And Consolidation Of Motor Skills In People With Multiple Sclerosis With Severe Gait Impair
NA · 1 location(s) · University Hospital of Ferrara · NCT07058896Long-Term Outcomes in SLE at Peking University People's Hospital
Phase N/A · 1 location(s) · Peking University People's Hospital · NCT07005479A Phase I Double Blind Study of Metformin Acting on Endogenous Neural Progenitor Cells in Children and Young Adults With
Phase 1/Phase 2 · 1 location(s) · The Hospital for Sick Children · NCT04121468Belimumab in Autoimmune Hepatitis
Phase 2 · 5 location(s) · University Health Network, Toronto · NCT06381453Prebiotics in Patients With Type 1 Diabetes
NA · 3 location(s) · University of Calgary · NCT04963777Visual Involvement in Giant Cell Arteritis
Phase N/A · 1 location(s) · ASST Fatebenefratelli Sacco · NCT06500728Apremilast Pediatric Study in Children With Active Juvenile Psoriatic Arthritis
Phase 3 · 45 location(s) · Amgen · NCT04804553Raman Spectroscopy Diagnosis of Kidney Diseases
Phase N/A · 1 location(s) · Zunsong Wang · NCT06760845Effects of Reiki and Self-Acupressure Applications
NA · 1 location(s) · Firat University · NCT07083856Monoclonal Antibody-Based Therapies for AQP4-Positive NMOSD
Phase N/A · 1 location(s) · Tongji Hospital · NCT06885957Advancing Portable Brain Imaging: The NextMRI Project's Role in Revolutionizing Diagnostic MRI
NA · 1 location(s) · Instituto de Investigacion Sanitaria La Fe · NCT07037966Psilocybin Therapy for Psychological Distress in Palliative Patients
Phase 2 · 4 location(s) · University Medical Center Groningen · NCT06782724Personalized Treatment in Thyroid Disorders
NA · 1 location(s) · Johns Hopkins University · NCT03517579Is [18F]-DPA-714 PET a Good Marker of Neuroinflammation in Autoimmune Encephalitis?
Phase 2 · 1 location(s) · University Hospital, Toulouse · NCT07488117Accuracy of Continuous Glucose Monitors During the Perioperative Period in Youth With Type 1 Diabetes
Phase N/A · 1 location(s) · University of Colorado, Denver · NCT06575842Glycemic Improvement With Team, Technology, Education and Peer Resources in Type 1 Diabetes-GLITTER Study
NA · 10 location(s) · Second Xiangya Hospital of Central South University · NCT07097805The Characteristics of Oral Microbiota in Chronic Pancreatitis and Autoimmune Pancreatitis
Phase N/A · 1 location(s) · Ruijin Hospital · NCT07015580VIBRANT: VIB4920 for Active Lupus Nephritis
Phase 2 · 17 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT05201469Interferon Signature in Anti-CTLA-4 and Anti-PD-1/PD-L1-Treated Cancer Patients Compared With Systemic Autoimmune Diseas
Phase N/A · 1 location(s) · Hospital Universitario Araba · NCT07249060Entire-body PET Scans for Multiple Sclerosis
EARLY_Phase 1 · 1 location(s) · Brain Health Alliance · NCT04390009The Anifrolumab PRIM Program
Phase N/A · 1 location(s) · AstraZeneca · NCT06795893Study Evaluating Safety, Tolerability, PK/PD of Surovatamig in Adult RA or SLE Participants
Phase 1 · 33 location(s) · AstraZeneca · NCT07201558Bacille Calmette-Guérin (BCG) Vaccine In Radiologically Isolated Syndrome (RIS)
Phase 2 · 1 location(s) · S. Andrea Hospital · NCT03888924Efficacy of the Omnipod® 6 System Compared With the Omnipod® 5 System
NA · 12 location(s) · Insulet Corporation · NCT07579702CD4^LVFOXP3 in Participants With IPEX
Phase 1 · 1 location(s) · Bacchetta, Rosa, MD · NCT05241444REDO-JAK: Dose Reduction of Janus Kinase Inhibitors in Patients With Inflammatory Rheumatic Diseases
Phase 4 · 7 location(s) · Sint Maartenskliniek · NCT07160231Evaluating Dyspnea in Autoimmune Myasthenia Gravis "Why am I Short of Breath?"
Phase N/A · 1 location(s) · Institut de Myologie, France · NCT06866652
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.